XORTX Therapeutics
XRTX
4 hedge funds and large institutions have $30K invested in XORTX Therapeutics in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 2 closing their positions.
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
33% more funds holding
Funds holding: 3 → 4 (+1)
0% less ownership
Funds ownership: 0% → 0% (-0%)
33% less capital invested
Capital invested by funds: $45K → $30K (-$15K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Osaic Holdings
Scottsdale,
Arizona
|
+$5.07K |
| 2 |
CA
Clearstead Advisors
Cleveland,
Ohio
|
+$3.38K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
+$563 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CIBC World Market
Toronto,
Ontario, Canada
|
-$11.3K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$8K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$1.13K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
CIBC World Market
Toronto,
Ontario, Canada
| $23K | -$11.3K | -20 | -30% |
|
|
2
Osaic Holdings
Scottsdale,
Arizona
| $4K | +$5.07K | +9 | New |
|
|
CA
3
Clearstead Advisors
Cleveland,
Ohio
| $3K | +$3.38K | +6 | New |
|
|
4
UBS Group
Zurich,
Switzerland
| – | -$8K | -14 | Closed |
|
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| – | -$1.13K | -2 | Closed |
|
|
6
Bank of America
Charlotte,
North Carolina
| – | +$563 | +1 | New |
|
XRTX Hedge Fund Activity: Q3 2022 in Review
4 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in XORTX Therapeutics (XRTX) for Q3 2022, worth a combined $30K — down 33% from $45K a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new XRTX positions and 2 closed out — a net gain of 1 holder — while 0 added to existing stakes and 1 trimmed.
The largest buyer was Osaic Holdings, opening a new position worth an estimated $5.07K. The largest seller was CIBC World Market, cutting an estimated $11.3K.
- 4 institutional investors held XORTX Therapeutics (XRTX) as of Q3 2022, up from 3 in Q2 2022.
- Funds reported $30K of XORTX Therapeutics stock for Q3 2022, down 33% quarter-over-quarter.
- 3 funds opened new XORTX Therapeutics positions in Q3 2022 and 2 closed out, a net change of +1 holder.
- The largest XORTX Therapeutics buyer in Q3 2022 was Osaic Holdings, an estimated $5.07K added.
- The largest XORTX Therapeutics seller in Q3 2022 was CIBC World Market, an estimated $11.3K sold.
Based on aggregated 13F filings for Q3 2022.